Read more about it
3 stories about ALS
ALS Drug Developer NeuroSense Crowdfunds $1.15 Million
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member
Tag does not exist. Please try again.